Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattii

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Firacative, Carolina ^a,b   Duan, Shuyao ^a   Meyer, Wieland ^a  

^a University of Sydney   (Australia)

^b INSTITUTO NACIONAL DE SALUD   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN;

ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CRYPTOCOCCUS GATTII; FUNGAL STRAIN; FUNGAL VIRULENCE; GALLERIA MELLONELLA; GENETIC ASSOCIATION; GROWTH RATE; INOCULATION; LARVA; MOLECULAR TYPING; NONHUMAN; PATHOGENICITY; PROTEIN SYNTHESIS; SURVIVAL RATE; ANIMAL; CRYPTOCOCCOSIS; DISEASE MODEL; MICROBIOLOGY; MOTH; VIRULENCE;

ANIMALS; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; DISEASE MODELS, ANIMAL; LARVA; MOTHS; VIRULENCE;

EID: 84926637078     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105076     Document Type: Article

References (51)

1. Bovers M, Hagen F, Boekhout T (2008) Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev Iberoam Micol 25:S4-S12. (Pubitemid 351518336)
2. Byrnes EJ, Bartlett KH, Perfect JR, Heitman J (2011) Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect 13:895-907.
3. Chayakulkeeree M, Perfect JR (2006) Cryptococcosis. Infect Dis Clin North Am 20:507-544. (Pubitemid 44375117)
4. Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A (2011) Cryptococcus: From Human Pathogen to Model Yeast. Washington, DC. ASM Press. 3-15 p.
5. Boekhout T, Theelen B, Diaz M, Fell JW, Hop WC, et al. (2001) Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 147:891-907. (Pubitemid 32401329)
6. Meyer W, Marszewska K, Amirmostofian M, Igreja RP, Hardtke C, et al. (1999) Molecular typing of global isolates of Cryptococcus neoformans var neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA - a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis 20:1790-1799. (Pubitemid 29320477)
7. Meyer W, Castañeda A, Jackson S, Huynh M, Castañeda E, et al. (2003) Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 9:189-195. (Pubitemid 36231789)
8. Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, et al. (2009) Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 47:561-570.
9. Ngamskulrungroj P, Gilgado F, Faganello J, Litvintseva AP, Leal AL, et al. (2009) Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS One 4:e5862.
10. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, et al. (2004) A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). PNAS 101:17258-17263. (Pubitemid 39627807)
11. Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, et al. (2005) Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437:1360-1364. (Pubitemid 41568682)
12. Byrnes EJ 3rd, Li W, Lewit Y, Perfect JR, Carter DA, et al. (2009) First reported case of Cryptococcus gattii in the Southeastern USA: implications for travel-associated acquisition of an emerging pathogen. PLoS One 4:e5851.
13. Sellers B, Hall P, Cine-Gowdie S, Hays AL, Patel K, et al. (2012) Cryptococcus gattii: an emerging fungal pathogen in the southeastern United States. Am J Med Sci 343:510-511.
14. Byrnes EJ 3rd, Li W, Lewit Y, Ma H, Voelz K, et al. (2010) Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 6:e1000850.
15. Carriconde F, Gilgado F, Arthur I, Ellis D, Malik R, et al. (2011) Clonality and α-a recombination in the Australian Cryptococcus gattii VGII population-an emerging outbreak in Australia. PLoS One 6:e16936.
16. Byrnes EJ III, Li W, Ren P, Lewit Y, Voelz K, et al. (2011) A diverse population of Cryptococcus gattii molecular type VGIII in Southern Californian HIV/AIDS patients. PLoS Pathog 7:e1002205.
17. Walraven CJ, Gerstein W, Hardison SE, Wormley F, Lockhart SR, et al. (2011) Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS One 6:e28625.
18. Cogliati M, Chandrashekar N, Esposto MC, Chandramuki A, Petrini B, et al. (2012) Cryptococcus gattii serotype-C strains isolated in Bangalore, Karnataka, India. Mycoses 55:262-268.
19. Escandón P, Sánchez A, Martínez M, Meyer W, Castañeda E (2006) Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia. FEMS Yeast Res 6:625-635.
20. Litvintseva AP, Thakur R, Reller LB, Mitchell TG (2005) Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J Infect Dis 192:888-892. (Pubitemid 41193087)
21. Loperena-Alvarez Y, Ren P, Li X, Schoonmaker-Bopp DJ, Ruiz A, et al. (2010) Genotypic characterization of environmental isolates of Cryptococcus gattii from Puerto Rico. Mycopathologia 170:279-285.
22. Olivares LR, Martínez KM, Cruz RM, Rivera MA, Meyer W, et al. (2009) Genotyping of Mexican Cryptococcus neoformans and C. gattii isolates by PCR-fingerprinting. Med Mycol 47:713-721.
23. Sukroongreung S, Nilakul C, Ruangsomboon O, Chuakul W, Eampokalap B (1996) Serotypes of Cryptococcus neoformans isolated from patients prior to and during the AIDS era in Thailand. Mycopathologia 135:75-78. (Pubitemid 27099378)
24. Chong HS, Dagg R, Malik R, Chen S, Carter D (2010) In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype. J Clin Microbiol 48:4115-4120.
25. Lockhart SR, Iqbal N, Bolden CB, DeBess EE, Marsden-Haug N, et al. (2012) Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility. Diagn Microbiol Infect Dis 73:144-148.
26. Trilles L, Meyer W, Wanke B, Guarro J, Lazéra M (2012) Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex. Med Mycol 50:328-332.
27. Thompson GR 3rd, Albert N, Hodge G, Wilson MD, Sykes JE, et al (2014) Phenotypic differences of Cryptococcus molecular types: implications for virulence in a Drosophila model of infection. Infect Immun 82:3058-3065.
28. Sabiiti W, May RC, Pursall ER (2012) Experimental models of cryptococcosis. Int J Microbiol 2012:626745.
29. García-Rodas R, Casadevall A, Rodríguez-Tudela JL, Cuenca-Estrella M, Zaragoza O (2011) Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS One 6:e24485.
30. Garcia-Solache MA, Izquierdo-Garcia D, Smith C, Bergman A, Casadevall A (2013) Fungal virulence in a lepidopteran model is an emergent property with deterministic features. MBio 4:e00100-13.
31. Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, et al. (2005) Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 73:3842-3850. (Pubitemid 40923121)
32. Chen YL, Lehman VN, Lewit Y, Averette AF, Heitman J (2013) Calcineurin governs thermotolerance and virulence of Cryptococcus gattii. G3 (Bethesda). 3:527-539.
33. Brennan M, Thomas DY, Whiteway M, Kavanagh K (2002) Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae FEMS Immunol Med Microbiol 34:153-157.
34. Dunphy GB, Oberholzer U, Whiteway M, Zakarian RJ, Boomer I (2003) Virulence of Candida albicans mutants toward larval Galleria mellonella (Insecta, Lepidoptera, Galleridae). Can J Microbiol 49:514-524. (Pubitemid 37510474)
35. Scorzoni L, de Lucas MP, Mesa-Arango AC, Fusco-Almeida AM, Lozano E, et al. (2013) Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile. PLoS One 8:e60047
36. Jackson JC, Higgins LA, Lin X (2009) Conidiation color mutants of Aspergillus fumigatus are highly pathogenic to the heterologous insect host Galleria mellonella. PLoS One 4:e4224.
37. Ngamskulrungroj P, Serena C, Gilgado F, Malik R, Meyer W (2011) Global VGIIa isolates are of comparable virulence to the major fatal Cryptococcus gattii Vancouver Island outbreak genotype. Clin Microbiol Infect 17:251-258.
38. Halliday CL, Bui T, Krockenberger M, Malik R, Ellis DH, et al. (1999) Presence of alpha and a mating types in environmental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia. J Clin Microbiol 37:2920-6. (Pubitemid 29391911)
39. Pukkila-Worley R, Gerrald QD, Kraus PR, Boily MJ, Davis MJ, et al (2005) Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot Cell 4:190-201. (Pubitemid 40234436)
40. Firacative C, Trilles L, Meyer W (2012) MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex. PLoS One 7:e37566.
41. Posteraro B, Vella A, Cogliati M, De Carolis E, Florio AR, et al. (2012) Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattii. J Clin Microbiol 50:2472-246.
42. Voelz K, Ma H, Phadke S, Byrnes EJ, Zhu P, et al. (2013) Transmission of hypervirulence traits via sexual reproduction within and between lineages of the human fungal pathogen Cryptococcus gattii. PLoS Genet 9:e1003771.
43. Krockenberger MB, Malik R, Ngamskulrungroj P, Trilles L, Escandón P, et al. (2010) Pathogenesis of pulmonary Cryptococcus gattii infection: a rat model. Mycopathologia 170:315-330.
44. Feldmesser M, Kress Y, Casadevall A (2001) Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147:2355-2365. (Pubitemid 32785515)
45. Zaragoza O, García-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodríguez-Tudela JL, et al. (2010) Fungal cell gigantism during mammalian infection. PLoS Pathog 6:e1000945.
46. McClelland EE, Bernhardt P, Casadevall A (2006) Estimating the relative contributions of virulence factors for pathogenic microbes. Infect Immun 74:1500-1504. (Pubitemid 43346782)
47. Steenbergen JN, Casadevall A (2003) The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect 5:667-675. (Pubitemid 36645127)
48. Zaragoza O, Casadevall A (2004) Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online 6:10-15.
49. Capilla J, Maffei CM, Clemons KV, Sobel RA, Stevens DA (2006) Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice. Med Mycol 44:601-610. (Pubitemid 44650509)
50. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, et al. (2000) Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 31:499-508. (Pubitemid 32289583)
51. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.